StockMarketWire.com - OptiBiotix Health said subsidiary ProBiotix Health had extended an original supply agreement with HLH BioPharma Vertriebs.

The agreement covered the supply of the company's cholesterol-reducing strain of LPLDL capsules and ran for three years from the date of signing.

It offered HLH a nonexclusive license to produce, package and commercialise products containing the strain in Austria, Switzerland and the United Arab Emirates.




Story provided by StockMarketWire.com